As an additional measure in the fight against Zika virus, the U.S. Food and Drug Administration announced that it has made available a panel of human plasma samples to aid in the regulatory evaluation of serological tests to detect recent Zika virus infection.
Pharma and biotech companies have been scrambling for years to develop therapies to treat patients with Alzheimer’s disease. As those companies look to develop treatments, MyndYou has created an artificial intelligence diagnostics tool to track the subtle changes in speech patterns of Alzheimer’s patients.
The EPICUP test is a new tool that helps identify up to 87% of cases of cancer of unknown origin (CUP).
Third Rock Ventures and GlaxoSmithKline’s SR One Launch Decibel Therapeutics With $52 Million, Expect to Hire 50-60 By Year End
Cochlear Implants, Cochlear Implants, Company Launches, Cystic Fibrosis, Diagnostic Tools, Diagnostics, Health, Hearing, Hirings, Launches, Launches, Oncology, Pediatric, Pediatric Cancer, Pediatrics, R&DBoston-based Third Rock Ventures announced today it had raised $52 million to launch a company called Decibel Therapeutics to work on hearing loss. Decibel Therapeutics will be headquartered at […]
PLEASANTON, Calif., July 30, 2015 /PRNewswire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced it has submitted the cobas® EGFR Mutation Test v2 for Premarket Approval (PMA) to the U.S. […]
WASHINGTON, July 19, 2015 /PRNewswire/ — Brain scans, memory tests and body fluids such as saliva may hold the keys to understanding a person’s likelihood of developing Alzheimer’s, even among […]
